Adenosine-to-inosine (A-to-I) microRNA editing is associated with tumor phenotypes in various cancer types. Recent analyses of The Cancer Genome Atlas (TCGA) dataset have shown several microRNAs that undergo A-to-I editing in human cancers, some of which have been reported to be associated with prognosis. Herein, we examined published small RNA deep sequencing data of 74 cases of lung adenocarcinoma (AD) and the corresponding normal counterpart (NC) specimen in silico in order to identify A-to-I microRNA editing events. Editing levels of miR-379-5p, miR99a-5p, and miR-497-5p were lower in AD than in NC and, in a large number of cases, the editing level of miR-200b-3p was higher in AD than in NC. Difference in the editing level between AD and NC was largest for miR-99a-5p. Then, we examined the editing level of miR-99a-5p in 50 surgically resected lung adenocarcinoma cases at our institution by a conventional sequence-based method, and its association with clinical outcomes. The editing level of miR-99a-5p was significantly lower in 19 cases of AD (38%) than in corresponding NC. These cases showed a shorter overall survival as assessed using the log-rank test (P = .047). This trend was consistent with previous analyses of TCGA dataset. The altered editing level of microRNAs in lung adenocarcinoma could serve as a potential biomarker.
most frequently edited. 10, 11 Since 2004, when primary microRNAs, precursors of microRNAs were first demonstrated to undergo A-to-I editing, 12 some studies have shown the role of microRNA editing in normal organs 13, 14 and various types of cancers. [15] [16] [17] MicroRNAs are single-stranded RNA molecules that are approximately 22 nucleotides in length and function as posttranscriptional gene regulators.
They bind to the 3′ UTR of mRNAs which contain a sequence complementary to the seed sequence (positions 2-8) on the microRNAs, resulting in degradation or downregulation of the target mRNAs. 18 As a consequence of microRNA editing, altered base complementation of a primary microRNA molecule affects the cleavage activity of microRNA processing proteins, DROSHA and DICER. 19, 20 Moreover, when the seed sequence of a microRNA undergoes RNA editing, the edited microRNA targets another set of mRNAs. Therefore, the alteration in the editing levels of microRNAs affects the phenotype of a cancer through the alterations of the gene expression profile. 13 Recently, in silico analyses of small RNA deep sequencing data of
The Cancer Genome Atlas (TCGA) dataset showed the comprehensive microRNA editing profile of 32 types of cancer. 21, 22 In the cases of lung adenocarcinoma, significant differences in the editing levels of 5 microRNAs (miR-200b-3p, miR-379-5p, miR-411-5p, miR-497-5p, and miR-99a-5p) were found between adenocarcinoma (AD)
samples and the corresponding normal counterpart (NC) samples, and correlations were found between the editing levels of 4 of these microRNAs (miR-376c-3p, miR-379-5p, miR-381-3p, and miR-99a-5p)
in AD and the survival of the patients.
In the present study, we analyzed the published small RNA deep sequencing data of 74 cases of lung adenocarcinoma, including the data of both AD and NC in silico, and detected 3 micro-
RNAs showing loss of editing in AD (the editing level was significantly lower in AD than in NC) and 1 microRNA showing gain of editing in AD (the editing level was significantly higher in AD than in NC). Regarding miR-99a-5p, which showed the largest difference of the editing level between AD and NC, we set up a conventional sequence-based method to quantify the editing levels. We examined surgically resected specimens from 50 cases of lung adenocarcinoma at our institution to detect differences of the editing level of miR-99a-5p between AD and NC. In our dataset, loss of editing of miR-99a-5p was significantly associated with shorter overall survival (OS), which was consistent with the analyses of TCGA dataset.
| MATERIALS AND METHODS

| In silico analysis of deep sequencing data
We searched the Sequence Read Archives (SRA) at the National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov/ sra) using a search phrase, "miRNA lung adenocarcinoma." We included paired data of lung adenocarcinomas and the corresponding normal tissues published before March 2015.
The downloaded SRA files were analyzed using perl scripts as previously described. 23, 24 In short, 5′ and 3′ adaptors were removed by Process_reads.pl. The reads were mapped to the human reference genome (hg38) using Bowtie. 25, 26 Here, we trimmed 2 bases at the 3′ end that undergo massive modifications. 27 We allowed a maximum of 1 mismatch per read with a quality score of at least 30, best unique alignment, and no cross-mapping. Then, the reads were remapped to the pre-microRNA sequence database by Analyze_muta- 
| Patient population and collection of samples
The study protocol was approved by the Institutional Ethical
Review Board at the University of Tokyo Hospital (Tokyo, Japan), and written informed consent was obtained from each patient. To confirm that the proportion of edited reads reflected the editing level of miR-99a-5p, the unedited amplicon which consists of the 5′ adaptor, unedited miR-99a-5p and polyA was ligated into the pGEM-T Easy Vector System (Promega). The edited amplicon was ligated similarly. Edited and unedited plasmids were mixed, so that the proportion of the copy number of the edited plasmids was 5%, 15%, and 25%. These 3 templates were amplified, concatenated, and sequenced by the same method described above until amplicons in excess of 100 were obtained for each template. GAPDH. For survival analysis, the cutoff values for high or low expression level were determined using receiver operating characteristic (ROC) curves. 30 The following primer sets were used: ADAR1 (F, 5′-ACC GGT GCT TCA ACA CTC TGA CTA-3′; R, 5′-CGG GAG ATT TCT GCA TGG-3′), ADAR2 (F, 5′-TGT CAA CTG GAC GGT AGG CGA CT-3′; R, 5′-TGC CGC CAG CTT GGA CTC AT-3′), and GAPDH (F, 5′-CAC CAC CAA TGC TTA GCA C-3′; R, 5′-TGG CAG GTT TTT CTA GAC GG-3′).
| Quantitative RT-PCR
| Statistical analysis
Student's t test (age) and Fisher's exact test (the others) were used to compare patient characteristics between the two groups. Statistical significance of the difference in the editing level between AD and NC was evaluated using the chi-squared test with Benjamini- was evaluated using Spearman's rank-order correlation test. All statistical analyses outside the perl scripts were carried out using IBM SPSS Statistics version 24 (IBM SPSS, Chicago, IL, USA). All the tests in this study were two sided, and the statistical significance level was set at P < .05.
| RESULTS
| In silico analysis of deep sequencing data
We downloaded the SRA files of 94 cases (188 samples) as candidates for analysis. They were from a single study which examined the relationship between smoking history and alteration of micro-RNA expression level in lung adenocarcinoma. 31 Twenty samples had an average spot length of 30 bases, and further analysis showed that these samples had extremely low alignment proportions of approximately 1% (mapped reads divided by total reads). Therefore, these 20 samples and corresponding tissue samples were excluded, and the remaining 148 samples were analyzed. Profiles of the 74 patients are shown in Table 2 .
The perl scripts output, including all mismatch types, included a total of 4518 significant mismatch events in 148 samples. The events were detected in 186 mismatch spots. We detected 64 mismatch hotspots, in which 1-base mismatch events were detected in F I G U R E 1 Schema of the method for quantifying the editing level of miR-99a-5p. Position 1 of miR-99a-5p is "A" in the absence of editing, and "I" with editing. First-strand cDNA carries "T" and "C", respectively. The proportion of edited miR-99a-5p is assumed to be constant before and after PCR and ligation. "GAATTC" in the PCR primer is the EcoRI site , and miR-6503-3p (n = 7): no significant differences of the editing level were observed in most cases. AD, adenocarcinoma; NC, normal counterpart a common mismatch spot in at least 10 samples. However, most of the non-A-to-G mismatch hotspots had extremely low mismatch frequencies (the number of reads with a mismatch divided by the number of total mapped reads) and were detected in fewer samples than the A-to-G mismatch hotspots (Figure 2 ). Therefore, we regarded the non-A-to-G mismatch hotspots as noises, random sequencing errors which could not be eliminated by statistical procedure in the perl scripts. In regard to the 10 A-to-G mismatch hotspots, all of them were also detected in the previous study of TCGA dataset. 22 These mismatch hotspots can be regarded as true editing sites, because they were firmly reproducible; we call them "editing hotspots" from here.
For the 10 A-to-I editing hotspots, we compared the editing levels 
A, Editing levels of miR-99a-5p in the 50 cases at our institution. The format of the scatter plot is the same as that in Figure 2 . B-D, Kaplan-Meier curves of the overall survival and the recurrence-free survival, stratified by loss of editing of miR-99a-5p. D, represents the subgroup of pathological stage IB disease (n = 23)
| Quantification of the editing level of miR-99a-5p
Our improved method to quantify the editing level of miR-99a-5p
shown in Figure 1 is based on two assumptions: (i) PCR efficiency of edited and unedited miR-99a-5p is equivalent; and (ii) the proportion of edited and unedited amplicons in concatemers is equivalent to that before ligation. To confirm that the proportion of edited reads reflected the editing level of the sample, we examined the standard template which contains 5%, 15%, and 25% edited amplicons (5′ adaptor, miR-99a-5p, and polyA). As shown in Table 3, each template showed results consistent with its mixture fractions.
Next, we extracted total RNA from 100 resected tissue specimens obtained from a cohort of 50 cases of lung adenocarcinoma and examined the editing level of miR-99a-5p in these specimens. In 43 cases (86%), the editing level in AD was lower than that in NC.
After statistical analysis, 19 cases (38%) showed significant loss of editing and 1 case (2%) showed significant gain of editing ( Figure 4A ). (Figure 5A ), consistent with a previous study in which miR-99a-5p was reported to be edited by ADAR2. 21 Then, the patients were divided into 2 groups according to the expression level (ΔΔCt value) of ADAR1 (high group, n = 24; low group, n = 26) and ADAR2 (high group; n = 17, low group; n = 33).
T A B L E 4
Comparison of the editing levels of the 8 microRNAs among the 3 datasets: the University of Tokyo Hospital, SRA, and TCGA 
| DISCUSSION
In the present study, in silico analysis identified 8 microRNAs with paired A-to-I editing hotspots. Furthermore, we demonstrated an improved method to quantify the editing level of miR-99a-5p. In our patient cohort, loss of editing was associated with poor prognosis after complete resection of lung adenocarcinoma. This tendency was consistent with the results of previous studies of TCGA dataset; 21, 22 reproducibility was confirmed by a well-validated conventional RT-PCR method. Along with these studies, we believe that the alteration of microRNA editing in lung adenocarcinoma could serve as a potential biomarker for predicting patient outcomes.
Before this biomarker can be applied practically in clinical medicine, the method for quantifying the editing level of microRNA needs to be further refined. In the first study to report microRNA editing, the authors amplified the precursor of miR-22, pri-miR-22, cloned the PCR product and sequenced at least 100 amplicons. 12 However, because editing of a primary microRNA affects the processing efficiency of the microRNA catalyzed by the double-strand RNase enzymes, DROSHA and DICER, the editing level of primary microRNA is not always equal to the editing level of mature microRNA, which finally functions as the posttranscriptional regulator. 32, 33 A recent comprehensive analysis showed that the difference in the editing level between a primary microRNA and mature microRNA is >10% in approximately half of the microRNAs. 34 An improved method to amplify mature microRNA was published in 2012. 28 In this study, mature microRNA was 3′ polyadenylated and 5′ adaptor ligated, reverse-transcribed with oligodT primer, specifically amplified, and cloned. At least 100 amplicons were sequenced. Use of the TaqMan Advanced miRNA cDNA Synthesis Kit (Thermo Fisher Scientific) reduced the operation hours of this method. Furthermore, to reduce cost entailed by the vast amount of sequencing, we made use of the concept of serial analysis of gene expression (SAGE) 29 and established a protocol to concatenate the amplicons, as described above. Our improved method takes approximately 6 extra hours to concatenate the amplicon, while the number of sequenced samples was almost one-half (5322 samples used to sequence 11 110 amplicons). Moreover, our validation experiment showed the reliability of this method.
Another candidate method, which would be less time-consuming and less expensive, is to make use of TaqMan MGB (minor groove binder) Probe with 2 colors of fluorescent dye. After synthesizing firststrand cDNA with the 5′ adaptor and polyA using TaqMan Advanced miRNA cDNA Synthesis Kit, the expression level of each microRNA can be quantified with a specific primer set and TaqMan MGB Probe, the editing level of mRNA was established in a previous study. 35 Combining these methods, both the expression and editing levels of microRNAs can be measured. A significant difficulty is that while securing the specificity of amplifying the microRNA, there is little space left for the TaqMan Probe to anneal on the editing spot, even with an MGB.
Previous studies have shown that miR-99a-5p itself functions as a tumor-suppressing microRNA through repressing invasion, migration, 36 and stemness. 37 However, the functional impact of editing miR-99a-5p is not clear, because it undergoes RNA editing at position 1. The seed sequence of the microRNAs, spanning positions 2-8, must be completely complementary to the 3′ UTR part of the target mRNA. 18 A previous study reported that miR-17-5p and miR-106a-5p, whose sequences differ only in position 1, are regulated and function in parallel. 38 Although the previous study of TCGA dataset showed that the editing level of miR-99a-5p was correlated with the mutation frequency of 14 important genes, including TP53, HRAS, NRAS and PIK3CA in 6 cancer types, 21 this cannot be explained by the known function of microRNA editing. Therefore, we assume that the difference in the editing level of miR-99a-5p being the largest among the paired editing hotspots caused a "passenger change" in lung adenocarcinoma, rather than alteration of a specific function of miR-99a-5p.
In a previous study of TCGA dataset, expression level of ADAR1 in lung adenocarcinoma was reported to be upregulated as compared with that in the corresponding normal tissue. 39 Moreover, amplification of the ADAR1 region 40 and higher expression level of ADAR1 in cancerous tissue 21 were associated with a tendency toward a poorer prognosis, although the association was not statistically significant for either. Our dataset showed an inverse tendency. We did not identify any clinical features (age, gender, smoking history, stage, EGFR mutation status) that were significantly associated with the expression levels of ADAR1 in our dataset. The largest difference between our cohort and TCGA cohort was in the ethnicity of the patients (100% East Asian vs 67.2%
White and 1.4% Asian), which may have affected tumor biogenesis. We consider that study of more cases is needed to verify the function of ADAR1 in lung adenocarcinoma. Regarding ADAR2, our findings were consistent with previous studies; ADAR2 was downregulated in lung adenocarcinoma tissues, 39 and a lower ADAR2 expression level was significantly associated with a poorer prognosis. 
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